IRIS
CARAMORI, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.123
EU - Europa 9.389
AS - Asia 7.897
SA - Sud America 3.707
Continente sconosciuto - Info sul continente non disponibili 542
AF - Africa 235
OC - Oceania 13
Totale 41.906
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.657
RU - Federazione Russa 5.473
BR - Brasile 3.118
SG - Singapore 2.959
CN - Cina 2.436
IE - Irlanda 1.417
HK - Hong Kong 880
IT - Italia 779
VN - Vietnam 690
SE - Svezia 589
FR - Francia 384
AR - Argentina 213
DE - Germania 183
CA - Canada 165
BD - Bangladesh 146
IN - India 139
GB - Regno Unito 127
PL - Polonia 113
EC - Ecuador 107
CO - Colombia 88
ID - Indonesia 84
TR - Turchia 83
MX - Messico 82
FI - Finlandia 62
ZA - Sudafrica 62
IQ - Iraq 60
VE - Venezuela 54
UA - Ucraina 52
PY - Paraguay 42
IL - Israele 41
PK - Pakistan 41
UZ - Uzbekistan 39
MA - Marocco 38
JP - Giappone 37
CL - Cile 33
NL - Olanda 33
BE - Belgio 27
CR - Costa Rica 27
JM - Giamaica 27
AT - Austria 26
HN - Honduras 23
PE - Perù 23
TN - Tunisia 23
TT - Trinidad e Tobago 23
GT - Guatemala 22
ES - Italia 21
JO - Giordania 21
KE - Kenya 21
MY - Malesia 21
AE - Emirati Arabi Uniti 20
AZ - Azerbaigian 20
KZ - Kazakistan 19
UY - Uruguay 18
NI - Nicaragua 17
NP - Nepal 17
EG - Egitto 16
TH - Thailandia 15
PA - Panama 14
SC - Seychelles 14
AL - Albania 13
SA - Arabia Saudita 13
DO - Repubblica Dominicana 12
OM - Oman 12
PH - Filippine 12
PR - Porto Rico 12
AU - Australia 11
BG - Bulgaria 11
BO - Bolivia 11
CZ - Repubblica Ceca 11
SV - El Salvador 11
EE - Estonia 10
GP - Guadalupe 10
SN - Senegal 10
CH - Svizzera 9
DZ - Algeria 9
GE - Georgia 9
KR - Corea 9
LK - Sri Lanka 9
LT - Lituania 9
TW - Taiwan 9
CI - Costa d'Avorio 8
CW - ???statistics.table.value.countryCode.CW??? 8
ET - Etiopia 8
GR - Grecia 8
KG - Kirghizistan 8
AM - Armenia 7
BB - Barbados 7
BH - Bahrain 7
AO - Angola 6
IR - Iran 6
PS - Palestinian Territory 5
RS - Serbia 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
CG - Congo 4
LB - Libano 4
AG - Antigua e Barbuda 3
BN - Brunei Darussalam 3
Totale 41.318
Salva come PNG Salva come JPEG
Città #
Ashburn 2.050
Moscow 2.027
Dublin 1.417
Singapore 1.180
Hong Kong 874
Dallas 863
San Jose 712
Beijing 691
Chandler 537
Dearborn 511
The Dalles 440
Nyköping 397
Council Bluffs 395
Princeton 328
Lauterbourg 277
Jacksonville 272
Ho Chi Minh City 264
Atlanta 256
São Paulo 254
Los Angeles 235
Des Moines 234
San Mateo 224
Cambridge 219
Messina 199
Medford 167
Hanoi 143
Redondo Beach 128
Jinan 116
Tianjin 113
Buffalo 112
Santa Clara 110
Shenyang 110
Warsaw 108
New York 106
Rio de Janeiro 94
Belo Horizonte 76
Guangzhou 68
Orem 66
Nanjing 64
Munich 62
Curitiba 61
Wilmington 61
Memphis 59
Ningbo 58
Zhengzhou 57
North Bergen 55
Milan 51
Rome 51
Brasília 50
Ann Arbor 49
Hebei 47
Naples 46
Bremen 45
Shanghai 40
Haikou 39
Nanchang 39
Porto Alegre 39
Campinas 38
Lanzhou 38
Tashkent 38
Chicago 37
Hangzhou 37
Montreal 37
Pune 37
Brooklyn 36
Haiphong 36
Salvador 35
San Francisco 35
Quito 34
Turku 34
Denver 33
Phoenix 32
Tokyo 30
Bogotá 28
Guarulhos 28
Guayaquil 28
Taizhou 28
Baghdad 26
London 26
Ribeirão Preto 26
Chennai 25
Seattle 25
Brussels 24
Da Nang 24
Santo André 24
Jakarta 23
Asunción 22
Changsha 22
Fortaleza 22
Frankfurt am Main 22
Shenzhen 22
Istanbul 21
San José 21
Dhaka 20
Fuzhou 20
Goiânia 20
Johannesburg 20
Thái Bình 20
Caxias do Sul 19
Maceió 19
Totale 18.538
Salva come PNG Salva come JPEG
Nome #
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 352
HLA-C*17 in COVID-19 patients: hints for associations with severe clinical outcome and cardiovascular risk 270
Polmonite interstiziale fibrosante da amiodarone 270
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 236
Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study. 229
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease 226
Anti-inflammatory mechanisms of glucocorticoids targeting granulocytes. 222
An unusual cause of chest pain 220
Attuali progressi nel trattamento dell’asma bronchiale nell’adulto. 217
Cytokine inhibition in the treatment of COPD. 215
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 215
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 214
Overlap and common correlates between depression and COPD: a narrative review 213
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 210
AN UNUSUAL CASE OF CHRONIC AIRFLOW OBSTRUCTION IN A HEAVY SMOKER 210
Near-fatal asthma phenotype in the ENFUMOSA Cohort. 208
Increased deposition of activated complement in peripheral lung vessels of smokers 208
Malattie virali dell’apparato respiratorio 207
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 206
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 205
New insights into the molecular mechanisms of corticosteroids actions. 205
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 205
Quality of life in asthma and COPD: is it measurable in primary care? 204
Asma. 202
Molecular links between COPD and lung cancer: new targets for drug discovery? 202
A case of fibrosing interstitial pneumonia 201
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 200
Anti-inflammatory treatments for asthma: past, present, future. 199
COPD immunopathology 199
I glucocorticoidi inalatori sono poco efficaci nel trattamento delle BPCO in fase stabile. 199
Congenital diaphragmatic hernia in an adult simulating a pleural liposarcoma. 198
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: patologia. 198
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. 198
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. 198
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 198
Effect of acute and chronic inflammatory stimuli on expression of protease-activated receptors 1 and 2 in alveolar macrophages. 197
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients 197
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 197
An unusual cause of dyspnoea in a patient with chronic ischemic heart disease 196
Nuove linee guida internazionali per la terapia farmacologica dell’asma. 195
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 195
Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. 194
Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. 193
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 193
Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages. 193
Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD 192
Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophages. 192
Parassiti e polmoni. 191
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 191
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. 190
New drugs targeting Th2 lymphocytes in asthma. 190
Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease? 188
Cellule staminali e patologia polmonare dell’adulto 188
Mechanisms of respiratory virus-induced asthma exacerbations 188
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 188
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis 188
Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. 187
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 186
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 186
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. 186
Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease 186
Increased expression of ccl4/mip-1β in cd8+ cells and cd4+ cells in sarcoidosis. 186
Decreased percentage of CD4+Foxp3+TGF-β+ and increased percentage of CD4+IL-17+ cells in bronchoalveolar lavage of asthmatics 186
Targeting Th2 cells in asthmatic patients. 185
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 185
Autoimmunity and COPD: Clinical Implications 185
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 184
Teofillina: effetti polmonari ed extrapolmonari nei pazienti con asma e BPCO; nuove prospettive. 184
Clinical definition of COPD exacerbations and classification of their severity. 184
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 184
Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD. 184
Definition, clinical features, investigations and differential diagnosis in asthma 184
Smoking history effect on peripheral lung inflammation and gene transcription in chronic obstructive pulmonary disease 183
Fattori genetici nell’asma e nella BPCO. 182
COPD in nonsmokers: the biomass hypothesis - to be or not to be? 182
Oxidants and asthma 181
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 181
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 180
Marcatori infiammatori nella diagnosi e nel monitoraggio dell’ asma. 180
Pathogenic link between chronic obstructive pulmonary disease and squamous cell lung cancer 179
Global lung function standardisation: finally making our dream a reality? 179
Patologia vascolare polmonare 179
Evaluation of Innate Immune Mediators Related to Respiratory Viruses in the Lung of Stable COPD Patients 179
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 178
Rhinovirus induces MUC5AC in a human infection model, and in vitro via NF-{kappa}B and EGFR pathways 177
Gli antagonisti dei leucotrieni: nuove speranze nella terapia dell'asma? 175
Broncodilatatori nella terapia delle broncopneumopatie croniche ostruttive. 175
[Risk of diabetes mellitus during regular long-term inhaled glucocorticoid treatment in COPD patients: narrative review of the literature.] 175
Evaluation by self-monitoring and noninvasive measures. 174
Decreased T-lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. 173
Cutting Edge: Hyperinflammatory Monocytes Expressing CD56 Abound in Severe COVID-19 Patients 172
Broncodilatatori nell’asma e nelle broncopneumopatie croniche ostruttive. 172
Subcutaneous emphysema of the chest wall: a case with unusual presentation. 172
Tubercolosi: vaccinazione e chemioprofilassi come prevenzione 172
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. 172
Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease 171
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 171
Role of the mucins in pathogenesis of COPD: implications for therapy 170
Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD 170
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance 169
Totale 19.480
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.317 0 0 0 0 27 13 181 87 19 72 335 583
2022/20232.889 365 187 104 152 133 182 35 96 1.547 8 52 28
2023/2024865 52 81 54 84 70 169 24 30 5 27 11 258
2024/20256.085 74 28 80 313 210 55 91 1.419 1.596 357 706 1.156
2025/202615.174 544 1.069 1.450 1.817 967 3.102 1.764 1.527 1.551 589 348 446
2026/202712.345 978 9.360 655 1.164 188 0 0 0 0 0 0 0
Totale 41.906